Sirolimus-eluting, bioabsorbable polymer-coated constant stent (Cura®) in acute ST-elevation myocardial infarction: A clinical and angiographic study (CURAMI registry)

Journal of Invasive Cardiology

Volumn 19, Issue 4, 2007, Pages 182-185

  Lee, Chi Hang ^a   Lim, Jimmy ^b   Low, Adrian ^b   Zhang, Xiao Ling ^b   Kyaing, Than Than ^b   Chan, Mark Y ^b   Wong, Hwee Bee ^b   Lim, Yean Teng ^b   Tan, Huay Cheem ^b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

POLYMER; RAPAMYCIN;

ADULT; ANGIOGRAPHY; ARTICLE; BIODEGRADABLE IMPLANT; CLINICAL ARTICLE; DEATH; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART REINFARCTION; HOSPITAL PATIENT; HUMAN; IMPLANTATION; MALE; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; REVASCULARIZATION; ST SEGMENT ELEVATION; THROMBOSIS;

AGED; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMERS; PROSTHESIS DESIGN; REGISTRIES; STENTS;

EID: 34147143306     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Moses JW, Leon MB, Popma JJ, et al. SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
2. Stone GW, Ellis SG, Cox DA, et al. TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
3. Nebeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with drug-eluting coronary stents: A review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006;47:175-181.
4. Azarbal B, Currier JW. Allergic reactions after the implantation of drug-eluting stents: Is it the pill or the polymer? J Am Coll Cardiol 2006;47:182-183.
5. Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious? Circulation 2004;109:701-705.
6. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-1521.
7. Lansky AJ, Costa RA, Mintz GS, et al. DELIVER Clinical Trial Investigators. Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: Angiographic follow-up of the DELIVER clinical trial. Circulation 2004;109:1948-1954.
8. Saia F, Lemos PA, Lee CH, et al. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: A clinical and angiographic study. Circulation 2003;108:1927-1929.
9. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999;341:1949-1956.
10. Stone GW, Grines CL, Cox DA, et al. Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002;346:957-966.